Products

What will AGI do for Befunolol hydrochloride?

This classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula C16H21NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B03Z2VY37I, chemically known as ethanone, 1-(7-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2-benzofuranyl)-, hydrochloride but more generally known as befunolol hydrochloride, which bears US NIH Compound Identifier 38286. European Medicines Agency schedules Befunolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00686MIG. Most nations, for tariff and trade purposes, schedule befunolol hydrochloride under HS 29329985 and SITC 51569. As of Q4 2014, BEFUNOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)NCC(COC1CCCC2C1OC(C2)C(=O)C)O.CL.